Bortezomib in plasmablastic lymphoma: a glimpse of hope for a hard-to-treat disease
TA Guerrero-Garcia, RJ Mogollon, JJ Castillo - Leukemia Research, 2017 - Elsevier
Plasmablastic lymphoma (PBL) is a rare and hard to treat disease. With current standard
chemotherapeutic regimens, PBL is associated with a median overall survival of 12–15 …
chemotherapeutic regimens, PBL is associated with a median overall survival of 12–15 …
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients …
C Dittus, N Grover, S Ellsworth, X Tan… - Leukemia & …, 2018 - Taylor & Francis
Plasmablastic lymphoma (PBL) is a rare and aggressive form of B-cell non-Hodgkin
lymphoma. This subtype of lymphoma has a post-germinal center cell-of-origin called the …
lymphoma. This subtype of lymphoma has a post-germinal center cell-of-origin called the …
Testicular plasmablastic lymphoma in an HIV-Negative patient: a rare case presentation
K Nwanwene, NAJ Khan… - Journal of Investigative …, 2021 - journals.sagepub.com
Plasmablastic lymphoma (PBL) is a very rare disease and it is usually considered a human
immunodeficiency virus (HIV)–related B-cell lymphoma that carries a poor prognosis. It …
immunodeficiency virus (HIV)–related B-cell lymphoma that carries a poor prognosis. It …
Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma
Plasmablastic lymphoma (PBL) is an aggressive form of non-Hodgkin's lymphoma (NHL)
classically seen in patients infected with the human immunodeficiency virus, but can also be …
classically seen in patients infected with the human immunodeficiency virus, but can also be …
Plasmablastic lymphoma: case report.
A Olvera-Acevedo, ML Espinoza-Sánchez… - Revista Medica del …, 2020 - europepmc.org
Conclusiones La presencia de disfunción orgánica relacionada con mieloma motivó la
búsqueda de dicha patología y se determinó la presencia de linfoma plasmablástico. La …
búsqueda de dicha patología y se determinó la presencia de linfoma plasmablástico. La …
Clinical Features and Prognosis of 60 Cases of HIV-negative Plasmablastic Lymphomas Patients
XU Wen**g, W Pei, MA Yueshi, GAO Li** - Cancer Research on …, 2021 - zlfzyj.com
Objective To investigate the clinical features and prognosis of HIV-negative plasmablastic
lymphoma (PBL) patients. Methods We collected HIV-negative PBL cases reported in our …
lymphoma (PBL) patients. Methods We collected HIV-negative PBL cases reported in our …
[PDF][PDF] Linfoma plasmablástico: reporte de un caso
A Olvera-Acevedo, ML Espinoza-Sánchez… - Revista Médica del …, 2020 - redalyc.org
Introducción: El linfoma plasmablástico es un linfoma no Hodgkin de alto grado. Se describe
en pacientes con infección por el virus de la inmunodeficiencia humana (VIH), en …
en pacientes con infección por el virus de la inmunodeficiencia humana (VIH), en …
[PDF][PDF] Endometriosis intestinal:¿ un reto diagnóstico para el médico internista?
A Olvera-Acevedo, J Cervantes-Bojalil… - Revista Médica del …, 2021 - redalyc.org
Introducción: Dentro del gran abanico de competencias características del médico clínico se
encuentra el abordaje diagnóstico del síndrome doloroso abdominal. Es bien sabido que el …
encuentra el abordaje diagnóstico del síndrome doloroso abdominal. Es bien sabido que el …
60 例 HIV 阴性浆母细胞淋巴瘤患者的临床特征及预后
许文婧， 王佩， 马玥诗， 高丽萍 - 肿瘤防治研究, 2021 - zlfzyj.com
60例HIV阴性浆母细胞淋巴瘤患者的临床特征及预后许文婧, 王佩, 马玥诗, 高丽萍引用本文: 许
文X Page 1 60例HIV阴性浆母细胞淋巴瘤患者的临床特征及预后 许文婧, 王佩, 马玥诗, 高丽萍 …
文X Page 1 60例HIV阴性浆母细胞淋巴瘤患者的临床特征及预后 许文婧, 王佩, 马玥诗, 高丽萍 …